Hemodynamics, fluids & transfusion

Determinants of fluid use and the association between volume of fluid used and effect of balanced solutions on mortality in critically ill patients: a secondary analysis of the Balanced Solution in Intensive Care Study (BaSICS) trial

Intensive Care MedPublished Secondary analysis of the BaSICS randomised trial

An erratum to this article was published (Intensive Care Med, Jan 2024 ↗)

Authors' conclusion

Baseline patient characteristics collected in the BaSICS trial explain less of the variance of fluid use during the first 3 days than the enrolling site. Volume of fluid used and the effects of BS appear to interact, mostly in the sepsis subgroup where there was a strong association between fluid use after enrollment and the effect of BS on 90-day mortality.

Study context

Population
Critically ill intensive care unit (ICU) patients in the BaSICS trialanalysed
Participants
10,505 patients
Comparison
Plasma-Lyte 148® vs 0.9% saline for ICU fluid therapy
Primary endpoint
Relative contribution of patient features vs enrolling site to volume of fluid used; modulation of BS effect on 90-day mortality by fluid volume
Follow-up
Up to day 3 after admission
Methodological detailsBayesian regression, frequentist mixed model, random forest, Bayesian network accounting for competing risks, subgroup analysis
  • Bayesian regression
  • Frequentist mixed model
  • Random forest
  • Bayesian network accounting for competing risks
  • Subgroup analysis

Primary result

As reported in the abstract

Volume of fluid used up to day 3 and variance explained by enrolling site · up to day 3
Variance explained by random effect (enrolling site), Bayesian regression; 95% CrI 0.24-0.41; of total model variance 0.33
0.32 (95% CrI 0.32-0.35)

Further findings

OutcomeAbsolute risk reduction (95% CrI)
90-day mortality, septic patients at high fluid use sites (site practice analysis; subgroup) · 0.98 probability of benefit; CrI- 0.13 (- 0.27 to - 0.01)

Interaction of fluid use and balanced solutions (BS) effect on 90-day mortality (patients alive and in ICU at 3 days)

Strong suggestion of interaction, driven mostly by lower mortality with BS vs 0.9% saline as fluid use increased in sepsis; consistent in Bayesian network analysis

Original publication

Determinants of fluid use and the association between volume of fluid used and effect of balanced solutions on mortality in critically ill patients: a secondary analysis of the BaSICS trial. Intensive Care Med. Published 27 November 2023. doi:10.1007/s00134-023-07264-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.